The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
maqsood7
you dont strike me as someone who is easily scared.....take it easy.... ..
see you later
Fighting against COVID risks is much easier than we think....apparently :-)
https://www.zerohedge.com/medical/can-masturbation-boost-your-immune-system-fight-covid
Pokerchips, I take it you are risk free of Covid? :-) Sorry that was literally below the belt.
It's none of my business but I guess you must have lost money on the stock. We all have had a few of those with wrong timing or wrong decision making but, in my case, I just move on or, on occasions, average down. You seem to have an engrained negative slant and spend a fair amount of time posting on a Company where you seemingly have no financial interest. Welcome to the world where pharmas use cash. Some soar and some crash but it is invariably on their results in clinical trials as opposed to cash burn - within reason. Just as oil stocks crash when they fail to strike after a drill.
You seem smart enough so I assume you know that already but, for whatever reason, you are trying to assess a pharma in the same manner as someone would for a engineering generic widget making company with (unlike MXC) no prospect of high growth or a globally beneficial medical break through.
I would have been reluctant to invest at the 8p dizzy heights, primarily because I try it get in a what I perceive to be ground floor levels. £50m m/cap for a pharma company that has advanced clinical trials for high value market sectors seems far too cheap and I expect the anomaly to be rectified as the phase 3 clinical trial progresses. It will attract a lot of short(ish) term investors.
NickE
Thanks for your view...and feedback !
This has actually been a share for me to learn a lot from...it has been a good exercise for me....there was initially an awful lot of rampers in here and my views came from being an "anti-ramper" more than anything... a fair few did get caught up in it and some are indeed waiting for the share price to catch up again to give them back their investment money ...
I haven't lost anything on this share... probably because I developed a more "realistic" view over the time period...served me well as it turned out...
Maybe now is the point to re-look at where things are now....
" £50m m/cap for a pharma company that has advanced clinical trials for high value market sectors seems far too cheap "
Can I suggest that you look at IMM - an immensely important phase 3 trial about to begin amongst all their other projects and investments ... MCAP £20m.. ..with a "robust financial position with an anticipated cash runway until the end of 2023." ...FDA news due imminently.... I do actually have experience of these trial type companies.... IMM are in fact repeating their trial as the first time didn't give results to a high enough level
maybe compare the two...
regards
Pokerchips, that's interesting about IMM and it has failed a couple of times now in trials. I'll take another look but last time gave it a wide berth. There were one or two pharma gurus who said the science didn't stack up. They were right last time so I'd suggest its history and perhaps chance of success is responsible for the valuation. Sometimes these things can create opportunities... once bitten etc. I'd say it sounds very high risk but without looking at how it has been revised then that's just an instinctive reaction.
Yes, I think twitter beings out a lot of one line deramping and ramping alike. Your views are always considered with supporting facts which is always good to see. Timing and sentiment is everything and I think inevitably with something like MXC the ramping crew will get in short-term. I've usually done okay when I've got in ahead of the herd especially when the prospects for a headline grabbing trial result such as MXC have are there.
The one thing that put me off MXC was the CLN's but I've taken the view that firstly, the share price might have formeda base and, secondly, even CLN's become meaningless if a successful trial result on Covid is announced and that brings new investor focus and some credibility to the other trials. I don't think they could have picked more publicity generating applications than Covid, brain cancer, Alzheimer's and dementia.
We will see and good luck in your investments as well. I quite like the look of Evgen Pharma as they are fully funded for a bit but I can't see to much to drive the stock forward for a bit aside from a private investor taking a sizeable stake.
Some sideliners will be buying at 2.40 plus now,lol.
2.65 is first consolidation imo.